Items tagged 'Treatment & care'

Paediatric haemophilia nurses describe what they learned about transition from child to adult haemophilia care during a visit to an adult HTC.
An overview of new and emerging VWD therapies currently being studied. Most are experimental but show promising directions for future care.
Jo Cameron explains who the National Blood Authority is and what it does with product funding, horizon scanning and the ABDR.
Jenny Morgan has joined AHCDO as the new Program Officer – Clinical Advisory.
The 2025 Conference highlighted groundbreaking novel therapies for bleeding disorders and how teamwork can transform lives.
The Lifestyle plenary highlighted connection and teamwork with your Haemophilia Treatment Centre to empower people with bleeding disorders to live well.
The session on women with bleeding disorders at the 2025 Conference explored a female-centric approach to treatment and care over the lifetime.
HFA has published haemophilia treatment fact sheets on clotting factor replacement therapy, bispecific antibody therapy, rebalancing therapies and gene therapy.
How can young people with bleeding disorders make the transition from paediatric to adult care without falling through the cracks?
At ISTH 2025 researchers shared advances in emerging therapies for haemophilia and von Willebrand disease (VWD).

Join the HFA community

Sign up for the latest news, events and our free National Haemophilia magazine

Skip to content